Tempus

Tempus is a technology company advancing precision medicine through the practical application of artificial intelligence in healthcare. With one of the world’s largest libraries of clinical and molecular data, and an operating system to make that data accessible and useful, Tempus enables physicians to make near real-time, data-driven decisions to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics. The goal is for each patient to benefit from the treatment of others who came before by providing physicians with tools that learn as the company gathers more data. For more information, visit tempus.com.

CancerIQ

CancerIQ helps providers use genetic information to predict, pre-empt, and prevent disease - starting with cancer. By making is easier to identify patients at risk, offer genetic evaluations at point of care, and design a tailored cancer prevention plan - we can help healthcare systems get ahead of this costly and emotionally devastating disease.

LanzaTech

It’s not a debate. There’s no two sides. A post-pollution world is inevitable. Humans will either be part of it, or the planet will go on without us. In other words, it’s defossilize or die. But where others see a dire choice, LanzaTech sees a trillion-dollar opportunity. The good news is after 15 years, north of a thousand patents, and millions of hours of pioneering scientific inquiry, LanzaTech has invented a technology big enough to meet the moment. One that transforms pollution into profit, and ensures that humans continue to prosper far into the post-pollution future. The science is state-of-the-art, but the idea is simple. We use nature to heal nature. First we capture carbon emissions. Then we feed them into bioreactors where trillions of carbon-hungry microbes go to work. These tiny dynamos eat the pollution and output valuable raw material commodities. Pure enough to be resold, repurposed, recycled, renewed, re-everythinged — from sustainable jet fuel to yoga pants. It’s a commercial scale solution that’s ready for market today. In a crowded sector filled with speculation but short on results, our plug-and-play platform is already making our customers money. Turns out science and business makes one helluva team. Waste carbon pollution is humanity’s biggest threat. LanzaTech is turning it into an opportunity. Reducing emissions and making money for our customers — today. Let's transform our tired Lose-Lose climate debate into a Win-Win proposition. One that helps companies grow their revenue while helping the planet reach a post-pollution reality.

Gerresheimer

Gerresheimer is the global partner for pharma, biotech, healthcare and cosmetics with a very broad product range for pharmaceutical and cosmetic packaging and drug delivery devices. The company is an innovative solution provider from concept to delivery of the end product. Gerresheimer achieves its ambitious goals through a high level of innovative strength, industrial competence, focus on quality and customers. In developing innovative and sustainable solutions, Gerresheimer relies on a comprehensive international network with numerous innovation and production centers in Europe, America and Asia. Gerresheimer produces close to its customers worldwide with around 10,000 employees and generates annual sales of more than €1.5 billion. With its products and solutions, Gerresheimer plays an essential role in people's health and well-being.